Ground Swell Capital’s Intelligent Bio Solutions INBS Stock Holding History

Ground Swell Capital’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,040	Closed	-$14.6K	–	198
2024 Q4	$14.6K	Buy	+1,040	New	+$15.9K	0.02%	127

Other funds holding INBS

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Ground Swell Capital's INBS Position: Q1 2025 in Review

Ground Swell Capital sold out of Intelligent Bio Solutions (INBS) in Q1 2025, closing a stake of 1,040 shares — an estimated $14.6K sold.

Ground Swell Capital first reported a position in INBS in Q4 2024 and held it in 1 quarter. The position peaked at $14.6K in Q4 2024. 8 funds tracked by Wall St. Rank hold INBS as of Q1 2025.

Ground Swell Capital reported no remaining Intelligent Bio Solutions position as of Q1 2025 after selling out during the quarter.
Ground Swell Capital sold 1,040 Intelligent Bio Solutions shares in Q1 2025, an estimated $14.6K.
Ground Swell Capital first reported a position in Intelligent Bio Solutions in Q4 2024 and held it in 1 quarter.
Ground Swell Capital's Intelligent Bio Solutions position peaked at $14.6K in Q4 2024.
8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2025.

Based on Ground Swell Capital's 13F filing for Q1 2025, filed 13 May 2025.